ColumbiaMagazine.com
Printed from:

Welcome to Columbia Magazine  
 



































 
Doctor convicted in oxycodone case at Georgetown pain clinic

Cincinnati physician convicted of illegally distributing oxycodone at Central Kentucky Bariatric and Pain Management
Click on headline for complete story

From U.S. Attorney's Office
U.S. Department of Justice, Eastern District of Kentucky

LEXINGTON, Ky. -- Yesterday, Alan Arnold Godofsky, 61, of Cincinnati, was found guilty by a federal jury, on five counts of distributing oxycodone outside the scope of professional medical practice and not for a legitimate medical purpose. The jury returned its guilty verdict after seven days of trial.



The evidence at trial established that, from March 2011 through January 2012, Godofsky worked as a physician at Central Kentucky Bariatric and Pain Management, in Georgetown. The evidence further established that, during this period, Godofsky prescribed significant quantities of oxycodone pills to patients, outside the scope of professional medical practice and without a legitimate medical purpose. Specifically, the evidence established that he prescribed these drugs without conducting examinations, without obtaining informed consent, and to patients who had no legitimate medical need.

"Sadly, this case represents yet another example of a physician abdicating his professional responsibility to his patients, placing his own profit over sound medical judgment, and fueling the opioid epidemic," said Carlton S. Shier, IV, Acting United States Attorney for the Eastern District of Kentucky. "Prescription opioid abuse has decimated our community and the prosecution of medical professionals who betray the trust of patients and illegally dispense these highly addictive medications has been, and will continue to be, a priority for our office. We appreciate the great work of our law enforcement partners in this case; without them, this important prosecution would not have been possible."

Acting United States Attorney Shier; Timothy J. Plancon, Special Agent in Charge, Drug Enforcement Administration; Andy Beshear, Attorney General of Kentucky; Richard Sanders, Commissioner, Kentucky State Police; and Steven Davis, Acting Inspector General, Kentucky Cabinet for Health and Family Services, jointly announced the verdict.

Godofsky is scheduled to be formally sentenced on January 24, 2018. The investigation was conducted by the DEA, the Kentucky Attorney General's Office, the KSP, and the CHFS Office of the Inspector General. The United States was represented by Assistant United States Attorney Ron L. Walker, Jr.


This story was posted on 2017-10-08 03:47:43
Printable: this page is now automatically formatted for printing.
Have comments or corrections for this story? Use our contact form and let us know.



 

































 
 
Quick Links to Popular Features


Looking for a story or picture?
Try our Photo Archive or our Stories Archive for all the information that's appeared on ColumbiaMagazine.com.

 

Contact us: Columbia Magazine and columbiamagazine.com are published by Linda Waggener and Pen Waggener, PO Box 906, Columbia, KY 42728.
Phone: 270.403.0017


Please use our contact page, or send questions about technical issues with this site to webmaster@columbiamagazine.com. All logos and trademarks used on this site are property of their respective owners. All comments remain the property and responsibility of their posters, all articles and photos remain the property of their creators, and all the rest is copyright 1995-Present by Columbia Magazine. Privacy policy: use of this site requires no sharing of information. Voluntarily shared information may be published and made available to the public on this site and/or stored electronically. Anonymous submissions will be subject to additional verification. Cookies are not required to use our site. However, if you have cookies enabled in your web browser, some of our advertisers may use cookies for interest-based advertising across multiple domains. For more information about third-party advertising, visit the NAI web privacy site.